Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population

European Heart Journal

Volumn 26, Issue 3, 2005, Pages 279-287

  Furtner, Martin ^a   Kiechl, Stefan ^a   Mair, Artur ^a   Seppi, Klaus ^a   Weger, Siegfried ^b   Oberhollenzer, Friedrich ^b   Poewe, Werner ^a   Willeit, Johann ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b BRUNECK HOSPITAL   (Italy)

Author keywords

Atherosclerosis; Epidemiology; Peripheral vascular disease; Risk factors; Urinary albumin excretion

Indexed keywords

ALBUMIN; CREATININE; LIVER ENZYME; PARATHYROID HORMONE; SERUM ALBUMIN;

ADULT; AGED; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FEMORAL ARTERY; HUMAN; INFLAMMATION; INTIMA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS;

AGED; AGED, 80 AND OVER; ALBUMINURIA; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL; COHORT STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 13544256374     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi014     Document Type: Article

References (44)

1. National Kidney Foundation Kidney Disease Outcomes Quality Initiative Advisory Board: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39:546-564.
2. Hutchison AS, O'Reilly DSJ, MacCuisk AC. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 1988;34:2019-2021.
3. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-226.
4. Pedrinelli R, Giampietro O, Carmassi F et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994;344:14-18.
5. Jensen JS, Borch-Johnsen K, Jensen G et al. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Colch) 1995;88:629-633.
6. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426.
7. Valmadrid CT, Klein R, Moss SE et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000;160:1093-1100.
8. Viberti GC, Hill RD, Jarrett RJ et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430-1432.
9. Mathiesen ER, Ronn B, Storm B et al. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995;12:482-487.
10. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-360.
11. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-1418.
12. Agewall S, Wikstrand J, Ljungman S et al. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997;80:164-169.
13. Yudkin, JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988;2:530-533.
14. Mykkanen L, Zaccaro DJ, O'Leary DH et al. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997;28:1710-1716.
15. Bigazzi R, Bianchi S, Nenci R et al. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995;9:827-833.
16. Pedrinelli R, Dell'Omo G, Penno G et al. Dissociation between microalbuminuria and common carotid thickness in essential hypertensive men. J Hum Hypertens 2000;14:831-835.
17. Leoncini G, Sacchi G, Ravera M et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Hum Hypertens 2002;16:399-40-4.
18. Agewall S, Bjorn F. Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men. Atherosclerosis 2002;164:161-166.
19. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999;19:617-624.
20. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19:1992-1997.
21. Romundstad S, Holmen J, Kvenild K et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 2003;42:466-473.
22. Redon J, Williams B. Microalbuminuria in essential hypertension: redefining the threshold. J Hypertens 2002;20:353-355.
23. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb 1993;13:661-668.
24. Kiechl S, Willeit J. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol 1999;19:1484-1490.
25. Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol 1999;19:1491-1498.
26. Willeit J, Kiechl S, Oberhollenzer F et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 2000;20:529-537.
27. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-192.
28. Kiechl S, Werner P, Egger G et al. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Stroke 2002;33:2170-2176.
29. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197.
30. Mattix HJ, Hsu CY, Shaykevich S et al. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002;13:1034-1039.
31. Assadi FK. Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 2002;17:107-110.
32. Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999;22:307-313.
33. Hoogeveen EK, Kostense PJ, Jager A et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int 1998;54:203-209.
34. Damsgaard EM, Froland A, Jorgensen OD et al. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990;300:297-300.
35. Diercks GF, Stroes ES, van Boven AJ et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects. Atherosclerosis 2002;163:121-126.
36. Cirillo M, Senigalliesi L, Laurenzi M et al. Microalbuminuria in non-diabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med 1998;158:1933-1939.
37. Diercks GF, Stroes ES, Van Boven AJ et al. Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects. Diabetes Care 2002;25:936-937.
38. Yudkin JS. Microalbuminuria: a genetic link between diabetes and cardiovascular disease? Ann Med 1992;24:517-522.
39. Redon J, Liao Y, Lozano JV et al. Factors related to the presence of microalbuminuria in essential hypertension. J Hypertens 1995;13:463-469.
40. Festa A, D'Agostino R, Howard G et al. Inflammation and microalbuminuria in nondiabetic and typ. 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000;58:1703-1710.
41. Fajtova VT, Sayegh MH, Hickey N et al. Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 1995;57:329-335.
42. Baig NA, Herrine SK, Rubin R. Liver disease and diabetes mellitus. Clin Lab Med 2001;21:193-207.
43. Agewall S, Wikstrand J, Ljungman S et al. Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus. J Hypertens 1995;13:463-469.
44. Kim CH, Kim HK, Park JY et al. Association of microalbuminuria and atherosclerotic risk factors in non-diabetic subjects in Korea. Diabetes Res Clin Pract 1998;40:191-199.